News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MUELLER PETER
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $17.52, valued at
$297.8k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 14,500 options to buy
@ $37.86, valued at
$549k
|
|
| 05/26/2020 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $49.74, valued at
$994.8k
Granted 5,000 options to buy
@ $49.74, valued at
$248.7k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 08/26/2019 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 1,554 shares
@ $9.34, valued at
$14.5k
|
|
| 08/23/2019 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 1,800 shares
@ $8.42, valued at
$15.2k
Bought 6,646 shares
@ $8.83, valued at
$58.7k
|
|
| 05/28/2019 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 14,700 options to buy
@ $10.04, valued at
$147.6k
|
|
| 12/07/2018 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 1,295 shares
@ $5, valued at
$6.5k
Bought 100 shares
@ $5.01, valued at
$501
Bought 495 shares
@ $5, valued at
$2.5k
Bought 6,905 shares
@ $5.01, valued at
$34.6k
|
|
| 12/06/2018 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 1,076 shares
@ $5.09, valued at
$5.5k
Bought 325 shares
@ $5.11, valued at
$1.7k
Bought 344 shares
@ $5.12, valued at
$1.8k
Bought 200 shares
@ $5.13, valued at
$1k
Bought 2,062 shares
@ $5.15, valued at
$10.6k
|
|
| 03/13/2018 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 37,209 options
@ $11, valued at
$409.3k
|
|
| 03/07/2018 |
3
| MUELLER PETER (Director) has filed a Form 3 on BioXcel Therapeutics, Inc. |
| 06/18/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2014 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 500 shares
@ $66.13, valued at
$33.1k
Sold 6,400 shares
@ $67.49, valued at
$431.9k
Sold 600 shares
@ $68.08, valued at
$40.8k
Exercised 7,500 options to buy
@ $32.16, valued at
$241.2k
|
|
| 04/17/2014 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2,100 shares
@ $60.57, valued at
$127.2k
Sold 2,900 shares
@ $61.53, valued at
$178.4k
Sold 1,800 shares
@ $62.38, valued at
$112.3k
Sold 700 shares
@ $63.27, valued at
$44.3k
Exercised 1,750 options to buy
@ $28.84, valued at
$50.5k
Exercised 5,750 options to buy
@ $32.16, valued at
$184.9k
|
|
| 03/19/2014 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 6,280 shares
@ $78.19, valued at
$491k
Sold 1,220 shares
@ $78.78, valued at
$96.1k
Exercised 7,500 options to buy
@ $28.84, valued at
$216.3k
|
|
| 02/20/2014 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 6,867 shares
@ $82.55, valued at
$566.9k
Sold 633 shares
@ $83.05, valued at
$52.6k
Exercised 7,500 options to buy
@ $28.84, valued at
$216.3k
|
|
| 02/07/2014 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 17,250 shares
@ $0.01, valued at
$172.5
Granted 51,000 options to buy
@ $77.31, valued at
$3.9M
|
|
| 01/17/2014 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 7,500 shares
@ $78.67, valued at
$590k
Exercised 7,500 options to buy
@ $28.84, valued at
$216.3k
|
|
| 12/17/2013 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 5,400 shares
@ $64.4, valued at
$347.8k
Sold 2,100 shares
@ $65.42, valued at
$137.4k
Exercised 7,500 options to buy
@ $28.84, valued at
$216.3k
|
|
| 12/12/2013 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2,900 shares
@ $65.48, valued at
$189.9k
|
|
| 11/19/2013 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1,100 shares
@ $61.58, valued at
$67.7k
Sold 4,200 shares
@ $62.62, valued at
$263k
Sold 2,200 shares
@ $63.12, valued at
$138.9k
Exercised 3,000 options to buy
@ $18.93, valued at
$56.8k
Exercised 4,500 options to buy
@ $28.84, valued at
$129.8k
|
|
| 10/17/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/01/2013 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 34,000 options
@ $83.36, valued at
$2.8M
|
|
| 07/17/2013 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 4,965 shares
@ $86.17, valued at
$427.8k
Sold 2,535 shares
@ $86.66, valued at
$219.7k
Exercised 7,500 options
@ $18.93, valued at
$142k
|
|
| 10/16/2012 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 4,500 shares
@ $52.83, valued at
$237.7k
Sold 2,000 shares
@ $53.14, valued at
$106.3k
Exercised 6,500 options to buy
@ $16.32, valued at
$106.1k
|
|
| 09/19/2012 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 6,500 shares
@ $57.52, valued at
$373.9k
Exercised 6,500 options to buy
@ $16.32, valued at
$106.1k
|
|
| 08/17/2012 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2,400 shares
@ $53.84, valued at
$129.2k
Sold 4,100 shares
@ $54.3, valued at
$222.6k
Exercised 6,500 options to buy
@ $16.32, valued at
$106.1k
|
|
| 07/26/2012 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 36,250 options to buy
@ $48.74, valued at
$1.8M
|
|
| 06/19/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2012 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2,100 shares
@ $63.84, valued at
$134.1k
Sold 3,700 shares
@ $64.3, valued at
$237.9k
Sold 700 shares
@ $65.5, valued at
$45.9k
Exercised 6,500 options
@ $16.32, valued at
$106.1k
|
|
| 09/21/2011 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 25,000 shares
@ $52.5, valued at
$1.3M
Exercised 18,000 options
@ $17.16, valued at
$308.9k
Exercised 7,000 options
@ $18.93, valued at
$132.5k
|
|
| 08/30/2011 |
4
| MUELLER PETER (EVP, Global R&D, CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 9,500 shares
@ $45.01, valued at
$427.6k
Exercised 4,300 options
@ $10.41, valued at
$44.8k
Exercised 5,200 options
@ $11.27, valued at
$58.6k
|
|
|
|
|